IEL

IEL Limited is engaged in the business of manufacturing, trading, and marketing a variety of chemicals, pharmaceuticals, and drug intermediates. Management is committed to scaling up its trading and export business with the clear objective of enhancing value for its stakeholders. A key strategy involves concentrating on developing and diversifying into various chemical and commodity intermediates and derivatives that have high volume potential. The company has already established its operations in trading, exporting, and indenting for these products and is actively working to expand them. Recently, the company has expanded its business activities into warehousing, storage, godowns, and cold storage services. For the financial year 2023-24, total revenues saw a substantial increase to ₹17.26 crores compared to ₹11.05 crores in the prior year.;